REFERENCES
- Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry’s disease. Ceramide trihexosidase deficiency. N Engl J Med. 1967;276:1163–1167.
- Shabbeer J, Yasuda M, Luca E, Desnick RJ. Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype. Mol Genet Metab. 2002;76:23–30.
- Altarescu GM, Goldfarb LG, Park KY, . Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease. Clin Genet. 2001;60:46–51.
- von Scheidt W, Eng CM, Fitzmaurice TF, . An atypical variant of Fabry’s disease with manifestations confined to the myocardium. N Engl J Med. 1991;324:395–399.
- Schafer E, Baron K, Widmer U, . Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Hum Mutat. 2005;25:412.
- Niaudet P. Living donor kidney transplantation in patients with hereditary nephropathies. Nat Rev Nephrol. 2010;6:736–743.
- Popli S, Molnar ZV, Leehey DJ, . Involvement of renal allograft by Fabry’s disease. Am J Nephrol. 1987;7:316–318.